NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,307,196$26,144,0001.82%
Camber Capital Management LP 2,000,000$40,000,0001.37%
Birchview Capital, LP 92,000$1,840,0001.09%
MAVERICK CAPITAL LTD 5,858,316$117,166,0001.08%
Bellevue Group AG 3,954,604$79,093,0000.84%
CM Management, LLC 50,000$1,000,0000.74%
Goodman Financial Corp 106,238$2,125,0000.68%
Adero Partners, LLC 51,500$1,030,0000.46%
Duquesne Family Office 1,000,000$20,000,0000.44%
OSTERWEIS CAPITAL MANAGEMENT INC 394,929$7,899,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 566,082$11,322,0000.37%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,000$1,340,0000.35%
Hennion & Walsh Asset Management, Inc. 264,701$5,294,0000.32%
Virtus ETF Advisers LLC 35,476$710,0000.30%
DCF Advisers, LLC 31,300$626,0000.27%
PRIMECAP MANAGEMENT CO/CA/ 18,165,369$363,307,0000.25%
PDT Partners, LLC 164,016$3,280,0000.24%
LIBERTY WEALTH MANAGEMENT LLC 19,000$393,0000.19%
Invesco Ltd. 35,449,394$708,987,0000.19%
AdvisorNet Financial, Inc 129,777$2,596,0000.18%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.